These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21087732)

  • 1. Biomarker promise for Parkinson's disease.
    The Lancet Neurology
    Lancet Neurol; 2010 Dec; 9(12):1139. PubMed ID: 21087732
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities.
    Li S; Le W
    Neurosci Bull; 2017 Oct; 33(5):481-482. PubMed ID: 28936754
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of cognitive decline in Parkinson's disease.
    Lin CH; Wu RM
    Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in Parkinson's disease: an update.
    Shtilbans A; Henchcliffe C
    Curr Opin Neurol; 2012 Aug; 25(4):460-5. PubMed ID: 22772875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in Parkinson's disease.
    Dorsey ER; Holloway RG; Ravina BM
    Expert Rev Neurother; 2006 Jun; 6(6):823-31. PubMed ID: 16784406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.
    Schlossmacher MG; Mollenhauer B
    Biomark Med; 2010 Oct; 4(5):647-50. PubMed ID: 20945977
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards an expert system for accurate diagnosis and progress monitoring of Parkinson's disease.
    Alexiou A; Psiha M; Vlamos P
    Adv Exp Med Biol; 2015; 822():151-64. PubMed ID: 25416985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enabling biomarker discovery in Parkinson's disease using multiomics: challenges, promise and the future.
    Kiebish MA; Narain NR
    Per Med; 2019 Jan; 16(1):5-7. PubMed ID: 30422077
    [No Abstract]   [Full Text] [Related]  

  • 10. The Harvard Biomarker Study's big plan.
    Mohammadi D
    Lancet Neurol; 2013 Aug; 12(8):739-40. PubMed ID: 23809962
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinson's disease--the continuing search for biomarkers.
    Breen DP; Michell AW; Barker RA
    Clin Chem Lab Med; 2011 Mar; 49(3):393-401. PubMed ID: 21288170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
    Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
    Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
    Hattingen E; Magerkurth J; Pilatus U; Mozer A; Seifried C; Steinmetz H; Zanella F; Hilker R
    Brain; 2009 Dec; 132(Pt 12):3285-97. PubMed ID: 19952056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing predictive biomarkers for dementia of Parkinson's disease.
    Caviness JN; Aarsland D
    Expert Rev Neurother; 2011 Dec; 11(12):1661-3. PubMed ID: 22091589
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomarkers for Parkinson's disease.
    Graeber MB
    Exp Neurol; 2009 Apr; 216(2):249-53. PubMed ID: 19166835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinson's disease.
    Campolo J; De Maria R; Cozzi L; Parolini M; Bernardi S; Proserpio P; Nobili L; Gelosa G; Piccolo I; Agostoni EC; Trivella MG; Marraccini P
    J Neurol Sci; 2016 Nov; 370():167-172. PubMed ID: 27772753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NINDS boosts research for biomarkers in Parkinson's disease.
    Lancet Neurol; 2013 Mar; 12(3):217. PubMed ID: 23415560
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies.
    Alberio T; Fasano M
    J Biotechnol; 2011 Dec; 156(4):325-37. PubMed ID: 21925549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Welcome to the 11th Volume of Biomarkers in Medicine.
    Wilson H
    Biomark Med; 2017 Jan; 11(1):1-3. PubMed ID: 27967208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.